Protective Effect of Sevoflurane Preconditioning on Ischemia-reperfusion Injury in Patients Undergoing Reconstructive Plastic Surgery with Microsurgical Flap, a Randomized Controlled Trial
Overview
Authors
Affiliations
Background: In many clinical conditions that involve free flaps and tissue transplantations the possibility of minimizing ischemia-reperfusion injury can be a determinant factor for the success of the surgery itself. We hypothesize that preconditioning with sevoflurane is a protective factor against ischemia-reperfusion injury.
Methods: In this randomized controlled trial, patients ASA I-II undergoing breast reconstruction with deep inferior epigastric perforator flaps were allocated into two groups and analyzed: group BAL included patients who received balanced anesthesia with sevoflurane for 30 min before removal of the flap and throughout the surgery. The TCI group included patients who received a total intravenous anesthesia with propofol and remifentanil. We evaluated regional tissue oximetry at the end of the surgery and at 4, 12 and 20 h after surgery. Other assessed parameters were: blood lactate clearance, alanine aminotransferase, aspartate aminotransferase, lactic dehydrogenase, creatine phosphokinase.
Results: In total 54 patients, twenty-seven per group, were analyzed. There was a significant increase of the average value of regional tissue oximetry measured 4 h after surgery in the BAL group compared to the TCI group: BAL: 84.05 % (8.96 SD); TCI : 76.17 % (12.92 SD) (P = 0.03), but not at the other time frames. The creatine phosphokinase value was significantly lower in the BAL group at the end of surgery, but not at the other time-frames. There were no significant differences in blood levels of other markers.
Conclusions: From our results, the positive preconditioning impact of sevoflurane on ischemia-reperfusion injury in patients undergoing free flap surgery is expressed in the early postoperative hours, but it does not persist in the long-term.
Trial Registration: ClinicalTrial.gov identifier: NCT01905501 . Registered July 18, 2013.
Goswami U, Jain A J Anaesthesiol Clin Pharmacol. 2022; 37(4):499-504.
PMID: 35340956 PMC: 8944369. DOI: 10.4103/joacp.JOACP_22_20.
Oh C, Choi J, Park E, Piao L, Park H, Rhee K Biomed Res Int. 2021; 2021:8880267.
PMID: 33564684 PMC: 7850856. DOI: 10.1155/2021/8880267.
Yang L, Xu Y, Shen J, Lou F, Zhang J, Wu J Gland Surg. 2020; 9(5):1406-1414.
PMID: 33224816 PMC: 7667098. DOI: 10.21037/gs-20-225.
Ma X, Ouyang Y, Li C, Du X, Liu C Breast. 2020; 52:150.
PMID: 31982282 PMC: 7375551. DOI: 10.1016/j.breast.2020.01.002.
Xie D, Zhao J, Guo R, Jiao L, Zhang Y, Lau W Sci Rep. 2020; 10(1):23.
PMID: 31913350 PMC: 6949279. DOI: 10.1038/s41598-019-56897-8.